Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Celastrol: A lead compound that inhibits SARS‐CoV‐2 replication, the activity of viral and human cysteine proteases, and virus‐induced IL‐6 secretion
Carlos Alessandro Fuzo, Ronaldo B. Martins, Thais Fernanda de Campos Fraga‐Silva, et al.
Drug Development Research (2022) Vol. 83, Iss. 7, pp. 1623-1640
Open Access | Times Cited: 11

Showing 11 citing articles:

Discovery of PLpro and Mpro Inhibitors for SARS-CoV-2
Ana C. Puhl, André S. Godoy, G.D. Noske, et al.
ACS Omega (2023) Vol. 8, Iss. 25, pp. 22603-22612
Open Access | Times Cited: 11
Tripterin liposome relieves severe acute respiratory syndrome as a potent COVID-19 treatment
Haiying Que, Weiqi Hong, Tianxia Lan, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 19
Target identification by structure-based computational approaches: Recent advances and perspectives
Simona De Vita, Maria Giovanna Chini, Giuseppe Bifulco, et al.
Bioorganic & Medicinal Chemistry Letters (2023) Vol. 83, pp. 129171-129171
Open Access | Times Cited: 5
Exploring the Antiviral Potential of Esters of Cinnamic Acids with Quercetin
Valeria Manca, Annalisa Chianese, Vanessa Palmas, et al.
Viruses (2024) Vol. 16, Iss. 5, pp. 665-665
Open Access | Times Cited: 1
Insights for Future Pharmacology: Exploring Phytochemicals as Potential Inhibitors Targeting SARS-CoV-2 Papain-like Protease
Jawaria Jabeen, Nabeel Ahmed, Zunaira Shahzad, et al.
Future Pharmacology (2024) Vol. 4, Iss. 3, pp. 510-540
Open Access | Times Cited: 1
Neuroprotective Agents with Therapeutic Potential for COVID-19
César A. Zaa, Clara Espitia, Karen Lizbeth Reyes-Barrera, et al.
Biomolecules (2023) Vol. 13, Iss. 11, pp. 1585-1585
Open Access | Times Cited: 4
An outlook on the target‐based molecular mechanism of phytoconstituents as immunomodulators
Gazala Noor, Badruddeen Badruddeen, Juber Akhtar, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 11, pp. 5058-5079
Open Access | Times Cited: 3
The Evaluation of Drugs as Potential Modulators of the Trafficking and Maturation of ACE2, the SARS-CoV-2 Receptor
Nesreen F. Alkhofash, Bassam R. Ali
Biomolecules (2024) Vol. 14, Iss. 7, pp. 764-764
Open Access
Lessons learnt from broad-spectrum coronavirus antiviral drug discovery
Andrew A. Bolinger, Jun Li, Xuping Xie, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 9, pp. 1023-1041
Closed Access
Multi‐Targeted Antivirals
Bing Ye, Letian Song, Meehyein Kim, et al.
(2024), pp. 405-421
Closed Access
Page 1

Scroll to top